Checked
Cryoport, Inc.
Nasdaq: CYRX · Pharmaceutical Preparations · Brentwood, TN
- Revenue
- $176.2M
- +12.4% vs. prior year
- Net income
- $78.3M
- 44.4% net margin
- Total assets
- $765M
- Diluted EPS
- $1.40
Company details
As reported to the SEC
- SEC CIK
- 1124524
- Stock
- Nasdaq: CYRX
- Legal Entity Identifier (LEI)
- 9845004D8538BT8JF626
- Industry (SIC)
- Pharmaceutical Preparations (2834)
- Headquarters
- 112 Westwood Place, Suite 350, Brentwood, TN 37027
- Incorporated in
- Nevada
- Fiscal year end (SEC record)
- December 31
- Filer status
- Accelerated filer
- Phone
- (949) 232-1900
- Employer ID (EIN)
- 88-0313393
- Last annual report
- 03/05/2026
- Last quarterly report
- 08/06/2026
Formerly: CRYOPORT SYSTEMS INC (until 10/20/2005)
Annual financials
U.S. dollars, as tagged in each annual report's XBRL data. Later restatements replace earlier numbers. Select a date to open the filing.
| Fiscal year ended | 12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 |
|---|---|---|---|---|---|
| Revenue | $176.2M | $156.8M | $168.7M | $237.3M | $222.6M |
| Gross profit | $83.05M | $69.66M | $75.33M | $103.9M | $96.58M |
| Operating income | -$36.81M | -$121.7M | -$100.5M | -$31.9M | -$17.83M |
| Net income | $78.3M | -$114.8M | -$99.59M | -$37.33M | -$275.5M |
| Diluted earnings per share | $1.40 | -$2.49 | -$2.21 | -$0.93 | -$6.18 |
| Research and development | $17.04M | $17.71M | $18.04M | $15.72M | $16.84M |
| Total assets | $765M | $703.5M | $957.7M | $1.04B | $1.11B |
| Total liabilities | $262.4M | $301.6M | $468.7M | $482.9M | $471.1M |
| Shareholders' equity | $502.6M | $401.9M | $489M | $555.8M | $641.8M |
| Cash and cash equivalents | $250.5M | $34.14M | $35.19M | $29.23M | $139.1M |
| Cash from operations | -$8.58M | -$16.32M | -$757K | -$1.85M | $8.13M |
| Capital expenditures | $16.44M | $17.25M | $38.78M | $22.11M | $23.88M |
Federal and state records filed under the name Cryoport, Inc.
Matched by the company name and by the subsidiary names it lists in SEC filings and other public records, after removing endings like Inc., Corp. and Holdings. Records marked Subsidiary were filed under a subsidiary name. A subsidiary that is not listed in those records is not included, and an unrelated business with the same name can appear.
Trucking registrations
Motor carrier registrations with the Federal Motor Carrier Safety Administration
Swipe the table sideways to see more columns.
| Carrier | USDOT | Power units |
|---|---|---|
| Cryoport Systems IncIrvine, CA | 2964177 | 12 |
Subsidiaries
13 companies that Cryoport, Inc. owns or controls, as listed in its SEC annual report (Exhibit 21), GLEIF ownership records or USAspending
| Subsidiary | Listed in |
|---|---|
| Cryogene, Inc. | SEC 10-K |
| Cryoport Belgium SA | SEC 10-K |
| Cryoport France, SAS | SEC 10-K |
| Cryoport Germany, GmbH | SEC 10-K |
| Cryoport Japan GK | SEC 10-K |
| Cryoport Netherlands B.V. | GLEIF |
| Cryoport Netherlands BV | SEC 10-K |
| Cryoport UK Limited | SEC 10-K |
| MVE Biological Solutions (Chengdu) Co., Ltd. | SEC 10-K |
| MVE Biological Solutions Australia Pty Limited | SEC 10-K |
| MVE Biological Solutions Germany GmbH | SEC 10-K |
| MVE Biological Solutions US, LLC | SEC 10-K |
| TEC4MED LifeScience GmbH | SEC 10-K |
Recent filings
155 recent filings on record; insider ownership forms (3, 4, 5 and 144) are not listed here
Swipe the table sideways to see more columns.
24 insider ownership reports (Forms 3, 4, 5 and 144) were filed about Cryoport, Inc. in the last 12 months. They list trades by officers, directors and large holders; see them on SEC EDGAR.
Other pharmaceutical preparations
Swipe the table sideways to see more columns.
| Company | Headquarters | Revenue | Net income |
|---|---|---|---|
| Johnson & JohnsonJNJ | New Brunswick, NJ | $94.19B | $26.8B |
| Eli Lilly & CoLLY | Indianapolis, IN | $65.18B | $20.64B |
| Merck & Co., Inc.MRK | Rahway, NJ | $65.01B | $18.25B |
| Pfizer IncPFE | New York, NY | $62.58B | $7.77B |
| AbbVie Inc.ABBV | North Chicago, IL | $61.16B | $4.23B |
| Astrazeneca PLCAZN | Cambridge, United Kingdom | $58.74B | $10.22B |
| Bristol Myers Squibb CoBMY | Princeton, NJ | $48.19B | $7.05B |
| Abbott LaboratoriesABT | Abbott Park, IL | $44.33B | $6.52B |
Profile refreshed Oct 26, 2026; financials refreshed Oct 22, 2026.
Frequently asked questions
- What is Cryoport, Inc.'s CIK number?
- Cryoport, Inc.'s SEC Central Index Key (CIK) is 1124524.
- What is Cryoport, Inc.'s stock ticker?
- Cryoport, Inc. trades as Nasdaq: CYRX.
- What was Cryoport, Inc.'s revenue?
- Cryoport, Inc. reported revenue of $176.2M for the fiscal year ended Dec 31, 2025, +12.4% from the year before.
- When does Cryoport, Inc.'s fiscal year end?
- Cryoport, Inc.'s fiscal year end on file with the SEC is December 31; its most recent fiscal year ended Dec 31, 2025.
- Where is Cryoport, Inc. headquartered?
- Cryoport, Inc.'s principal executive office on file with the SEC is in Brentwood, TN.
- What companies does Cryoport, Inc. own?
- Cryoport, Inc. lists 13 subsidiaries in its SEC filings and other public records, including Cryogene, Inc., Cryoport Belgium SA, Cryoport France, SAS.
Source: U.S. Securities and Exchange Commission, EDGAR submissions and XBRL company facts · Last updated 10/26/2026